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The proteasome is considered the most important proteolytic system for removal of damaged proteins with aging. Using
ﬂuorogenic peptide substrates, the chymotrypsin-like, the trypsin-like, and the peptidylglutamyl peptidase activities of the
proteasome were measured in the soluble fractions of liver, brain, and lens rat homogenates. Speciﬁc activity was signiﬁcantly
decreased in liver and brain homogenates with maturation of the animal, that is, from newborn (7 days old) to fertile rats (2–
4 months old). Rat lens homogenate exhibited an increase in activity with maturation and also with aging. Chymotrypsin-like
activity was stimulated by calcium and this proteolytic activity was signiﬁcantly decreased with maturation of the rat brain. The
Michaelis-Menten constant (Km) increased with age in rat liver and lens, indicating a loss of aﬃnity for its substrates by the
proteasome in the animal with maturation and aging. The present data suggest that the loss of function of the proteasome with
maturation may be due to structural changes of the proteasome or a decreased content of regulatory components.
1.Introduction
In the science of aging, “the disposable soma theory”,
introduced by Kirkwood in 1977 [1], has become a helpful
concept in understanding of the processes that lead to
senescence and death. According to this theory, the primary
cause of aging is the accumulation of cellular and molecular
damage, that arises because of evolved limitations in somatic
maintenance and repair functions. One important form
of such damage accumulation is seen in the build-up of
aberrant proteins, which is reinforced by the age-related
impairment of protein degradation [2].
There are two major proteolytical systems responsible
for most intracellular protein turnover: the lysosomal and
the ubiquitin-proteasome system. For reviews see Jung et
al. 2009 [3] and Reinstein and Ciechanover 2006 [4].
Although protein degradation was originally considered
as an unregulated event, the discovery of the ubiquitin-
proteasome pathway in the early 1980s showed that this
process is indeed highly regulated. Proteins destined for
degradation by the proteasome are labeled with a small
protein, ubiquitin (Ub), through a series of reactions
involvingthreegroupsofenzymes:theUb-activatingenzyme
(E1), the Ub-conjugating enzymes (E2s), and the Ub-ligases
(E3s). Some of these conjugation-steps require ATP, but
the proteasome can act through both ATP-dependent/-
independent and Ub-dependent/independent mechanisms.
In recent years, the proteasome has been implied in highly
controlled events such as cell cycle regulation and processing
of antigens for presentation by the MHC class I pathways
[5]. However, it was ﬁrst described as a protein quality
control system, where misfolded or damaged proteins were
preferentially degraded by the proteasome. The ubiquitin-
proteasomepathwayisthereforeapotentialkeysysteminthe
biological defense against aging, but although several studies
have been performed to study age-related changes to the
proteasome itself, data have been inconclusive [6–12].2 Current Gerontology and Geriatrics Research
The purpose of the present study was to investigate
changes in proteasomal activity in several organs, including
the liver, the brain, and the eye lens, during the lifespan of
rats.
2.MaterialandMethods
2.1. Animals. Female white Sprague Dawley rats, 2–12
months old, were purchased from IﬀaC r e d o ,F r a n c e ,a n d
kept at the animal department at G¨ oteborg University for a
maximum of one year. For the youngest age groups in the
study, new rats, male and female, were generated through
breeding with male rats from Charles River Laboratories,
Germany. The animals were treated in accordance with
the NIH statement for the use of animals in research
and was approved by the regional ethics committee on
animal experimentation at the University of Gothenburg.
The following age groups and number of rats were included
in the study: 7 days (n = 23), 2 months (n = 6), 4 months
(n = 6), 10 months (n = 4), 18 months (n = 3–5), and
24 months (n = 4). All animals were sacriﬁced by CO2-
gas inhalation and the organs of interest (liver, brain, eyes)
removed and stored at −152◦C until use. Prior to freezing,
the eyes were dissected through a posterior approach and
the lenses were kept at −152◦C. Only clear lenses and organs
without obvious pathology (i.e., tumors) were used.
2.2. Preparation of Rat Organs. Prior to analysis, rat organs
were thawed, weighed, and homogenized on ice in 20mM
Tris buﬀer (pH 7.5), containing 5mM EDTA, 3mM NaN3,
and 1mM DTT. Homogenization was performed in a
teﬂon/glass homogenizer with 10 up-and-down strokes at
1,500rpm yielding homogenates of about 10% (for liver and
brain tissues) and 0.3% (lens homogenates) respectively. The
samples were centrifuged at 100,000g for 60min at +4◦C
after which the supernatant was saved for proteolytic anal-
ysis. Protein concentration was determined using Pierce’s
BCA Protein Assay Reagent B (Pierce, Rockford, Illinois) and
bovine serum albumin was used as standard.
2.3. Proteolytic Activity. The synthetic peptide substrates
used, Suc-Leu-Leu-Val-Tyr-AMC (LLVY) and Boc-Val-Gly-
Arg-AMC (VGR) were purchased from Bachem Fein-
chemikalien AG, Switzerland and Z-Leu-Leu-Glu-AMC
(LLE) was from Sigma Chemical CO, St Louis, MO. Stock
solutions of the three peptide substrates used in the study
were prepared as follows: LLVY and LLE were diluted to
40mM in 100% DMSO, whereas VGR was suspended to
10mM in 6% DMSO/aq. Prior to the proteolytic assay,
substrates were diluted in 20mM Tris (pH 7.5), with 5mM
EDTA and 3mM NaN3 and DTT was added to yield a
ﬁnal concentration of 2mM in the assay. For determination
of Km-values a wide range of substrate concentrations was
used; for LLVY between 12.5 and 100μM, for VGR 0.125 to
1mM, and for LLE the substrate concentration was varied
between 62.5 and 500μM (liver) or between 15 and 125μM
(brain and lens). For determination of speciﬁc activity, ﬁnal
substrate concentrations of 50μM (LLVY), 500μM (VGR),
and 62.5μM (LLE) were used. Speciﬁcity of the assay was
ensured using the proteasome speciﬁc inhibitor lactacystin
(10μM ﬁnal concentration). Proteolytic experiments were
also performed with addition of 5mM ATP and 0.02% SDS,
respectively, using 50μM LLVY as substrate.
Since LLVY is also a substrate for the calcium-dependent
protease calpain, additional experiments were run where
proteolysis was measured with 50μM LLVY in the presence
of 1mM calcium (1mM excess over EDTA). After sub-
traction with corresponding proteolytic activity measured
without calcium, the obtained diﬀerence w/wo calcium was
considered calcium-dependent. To ensure that the activity
thus detected was due to calpain, the assay was run with
addition of the speciﬁc calpain inhibitor calpastatin (10μM
ﬁnal concentration). In lens homogenates from older rats,
addition of calcium had a slightly inhibitory eﬀect in itself,
thus yielding a negative net calcium-dependent activity
according to the formula above. In these cases, activity was
set to zero.
Atthestartoftheproteolyticassay,100μLofsupernatant
and 100μl of substrate solution were added to a 96-well plate
(Dynex Technologies) and ﬂuorescence of the cleavage prod-
uct was measured over time at 37◦C in a microplate spec-
troﬂuorometer(SPECTRAmaxGEMINI,MolecularDevices,
Sunnyvale,CA), excitation wavelength 380nm, and emission
440nm. Activity was normally measured during 2 hours
and Vmax determined using SOFTmax PRO Version 2.6 as
software (Molecular Devices, Sunnyvale, CA). Proteolytic
activity is expressed as relative ﬂuorescence units per second
and gram of protein (RFU × s−1× g−1)a n dKm-values were
obtained from Lineweaver-Burk plots.
2.4. Statistical Analysis. Proteolytic activity was measured
in triplicates for each sample. To determine if Km-values
were aﬀected by age, regression analysis was performed.
For evaluation of changes in speciﬁc activity the rats were
divided into the following age groups: newborn (7 days old,
n = 23), young/fertile (2–4 months old, n = 12), middle
aged (10 months, n = 4), and old (18–24 months old,
n = 7–9), and statistical analysis was then performed using
ANOVA with Bonferroni as post hoc test to compensate
for multiple comparisons. A P-value of less than .05 was
considered statistically signiﬁcant. As software, Statview
(Abacus Concepts, Inc., Berkeley, CA) and SPSS 16.0 (SPSS,
Inc., Chicago, Il) were used.
3. Results
Activity of the three proteasomal peptidases (chymotrypsin-
like, trypsin-like, and peptidylglutamyl peptidase activities)
varied between age groups as shown in Tables 1, 2,a n d3.I n
rat brain, all three peptidases exhibited a signiﬁcant decrease
in speciﬁc activity from 7 days (newborn) to 2–4 months
of age (young/fertile). A signiﬁcant drop in proteasomal
activity between these two age groups was also seen in
rat liver, with regard to trypsin-like and peptidylglutamyl-
peptidase activities; for the chymotrypsin-like activity, the
decreased peptidase activity between 7 days to 2–4 monthsCurrent Gerontology and Geriatrics Research 3
Table 1: Proteasome activity in rat liver.
Type of activity Age Mean ± SD P-value
(Substrate) (RFU × s−1× g−1)
Chymotrypsin-like newborn 2.67 ±1.33
activity (LLVY) young/fertile 1.83 ±0.69 N.S.
middle aged 1.94 ±0.16 N.S.
old 3.73 ±0.98 .004∗
Calcium-dependent newborn 0.64 ±1.37
chymotrypsin-like activity young/fertile 0.24 ±0.29 N.S.
(LLVY w 1mM Ca2+ middle aged 0.32 ±0.24 N.S.
-L L V Yw oC a 2+) old 0.18 ±0.18 N.S.
Trypsin-like activity newborn 7.43 ±2.17
(VGR) young/fertile 3.29 ±1.07 .001†
middle aged 3.47 ±0.82 <.001†
old 4.01 ±0.75 <.001†
Peptidylglutamyl- newborn 2.50 ±0.64
peptidase activity (LLE) young/fertile 1.24 ±0.46 <.001†
middle aged 1.18 ±0.21 <.001†
old 1.22 ±0.20 <.001†
Chymotrypsin-like, trypsin-like, and peptidylglutamyl-peptidase activities in the soluble fractions of rat liver homogenate from newborn (7 days, n = 23),
young (2–4 months, n = 12), middle aged (10 months, n = 4), and old (18–24 months, n = 7) rats. Chymotrypsin-like activity was also measured with an
excess of calcium (1mM). Calcium-dependent chymotrypsin-like activity was deﬁned as the net diﬀerence between proteolysis of LLVY with and without
calcium, respectively. Proteolytic activity is expressed as relative ﬂuorescence units (RFUs) per second and gram of protein. Mean ± SD (standard deviation)
is shown. Statistical analysis was made using ANOVA with Bonferroni as post hoc. A P-value of less than .05 was considered statistically signiﬁcant. N.S. =
Not Signiﬁcant. ∗Signiﬁcant diﬀerence compared to the young group and †the newborn group.
was nonsigniﬁcant. No signiﬁcant changes in proteasome
activity was seen in rat liver and brain after the age of 2–4
months for any peptidases, except for the chymotrypsin-like
activityinliver,whereaslightincreasecouldbedetectedwith
aging. Proteasome activity in rat lens homogenate diﬀered
markedly from that of liver and brain. All three peptidases
activities increased continuously with maturation and aging,
from newborn to the very oldest animals. Addition of 5mM
ATP and 0.02% SDS, respectively, using 50μML L V Ya s
substrate, did not stimulate proteolytic activity (not shown).
Since LLVY can be a substrate for both the proteasome
(chymotrypsin-like activity) and the calcium-activated pro-
tease calpain, the assay using LLVY was performed both
without calcium (5mM EDTA) and with calcium (1mM
excess of Ca2+). The ratio of mean calcium-dependent versus
mean calcium-independent proteolysis of LLVY was 24%
(liver), 33% (brain), and 13% (lens), respectively for the
newborn group. For all organs investigated, there was a
decrease in calcium-dependent LLVY degradation between
the two youngest age groups (Tables 1–3), and in rat lens,
calcium-dependent activity was nondetectable for the older
age groups (Table 3). In most of the lenses from fertile and
old rats, addition of calcium even had a slightly inhibitory
eﬀect on proteolysis of LLVY (not shown). To investigate
the nature of the calcium-dependent degradation of LLVY,
calpastatin, an endogenous inhibitor of calpain, was added
to the assay. However, no inhibition by calpastatin was seen
(notshown).Incontrast,additionoftheproteasome-speciﬁc
inhibitor lactacystin reduced calcium-dependent proteolysis
to 10% of control. Calcium-independent degradation of
LLVY was inhibited by lactacystin to 2% as compared to
without inhibitor (rat brain homogenate, data not shown).
Proteolytic activity was measured using diﬀerent sub-
strate concentrations and the resulting Vmax was used for
generation of Lineweaver-Burk plots, from which Michaelis-
Menten constants (Km-values) were obtained. Km-values for
all three main proteasomal peptidases were plotted against
age and analysed using simple regression. In rat liver, all
threepeptidaseactivitiesexhibitedincreasingKm-valueswith
maturation/aging, although only the increase in Km for the
trypsin-like activity was signiﬁcant (Figure 1). In rat lens,
Km was signiﬁcantly elevated with age for both the trypsin-
like and the peptidylglutamyl peptidase activity, whereas the
chymotrypsin-like activity exhibited a nonsigniﬁcant decline
(Figure 3). Proteasome activity in rat brain diﬀered from




Although in recent years several studies have shown that
the activity of the proteasome decreases with aging [6–9],
contradictory data on this issue has long been and still
is a fact [10–12]. In this study, the trypsin-like and the
peptidylglutamyl peptidase activities in the soluble fraction
of rat liver homogenate were signiﬁcantly lower in rats older
than 2 months of age as compared to newborn rats (7 days
old). After the age of 2–4 months, no change in trypsin-
like or peptidylglutamyl peptidase activities could be seen,4 Current Gerontology and Geriatrics Research
Table 2: Proteasome activity in rat brain.
Type of activity Age Mean ± SD P-value
(Substrate) (RFU × s−1× g−1)
Chymotrypsin-like newborn 8.05 ±1.47
activity (LLVY) young/fertile 2.17 ±0.50 <.001†
middle aged 2.39 ±0.44 <.001†
old 2.76 ±0.41 <.001†
Calcium-dependent newborn 2.68 ±0.48
chymotrypsin-like activity young/fertile 1.11 ±0.28 <.001†
(LLVY w 1mM Ca2+ middle aged 1.18 ±0.29 <.001†
-L L V Yw oC a 2+) old 1.05 ±0.38 <.001†
Trypsin-like activity newborn 5.02 ±0.81
(VGR) young/fertile 1.57 ±0.22 <.001†
middle aged 1.63 ±0.30 <.001†
old 1.77 ±0.27 <.001†
Peptidylglutamyl- newborn 6.41 ±1.34
peptidase activity (LLE) young/fertile 1.72 ±0.31 <0.001†
middle aged 1.91 ±0.25 <.001†
old 2.00 ±0.39 <.001†
Chymotrypsin-like, trypsin-like, and peptidylglutamyl-peptidase activities in the soluble fractions of rat brain homogenate from newborn (7 days, n = 23),
young (2–4 months, n = 12), middle aged (10 months, n = 4), and old (18–24 months, n = 9) rats. Calcium-dependent chymotrypsin-like activity was
deﬁned as the net diﬀerence between proteolysis of LLVY with and without calcium, respectively. Proteolytic activity is expressed as relative ﬂuorescence units
(RFUs) per second and gram of protein. Mean ± SD (standard deviation) is shown. Statistical analysis was made using ANOVA with Bonferroni as post-hoc.
A P-value of less than .05 was considered statistically signiﬁcant. N.S. = Not Signiﬁcant. †denotes signiﬁcant diﬀerence compared to the newborn group.
Table 3: Proteasome activity in rat lens.
Type of activity Age Mean ± SD P-value
(Substrate) (RFU × s−1× g−1)
Chymotrypsin-like newborn 0.23 ±0.14
activity (LLVY) young/fertile 0.28 ±0.05 N.S.
middle aged 0.30 ±0.04 N.S.
old 0.36 ±0.11 .026∗
Calcium-dependent newborn 0.03 ±0.06
chymotrypsin-like activity young/fertile <0.00 N.A.
(LLVY w 1mM Ca2+ middle aged <0.00 N.A.
-L L V Yw oC a 2+) old <0.00 N.A.
Trypsin-like activity newborn 0.15 ±0.07
(VGR) young/fertile 0.20 ±0.04 N.S.
middle aged 0.24 ±0.03 N.S.
old 0.37 ±0.10 <.001∗†,.030‡
Peptidylglutamyl- newborn 0.21 ±0.08
peptidase activity (LLE) young/fertile 0.29 ±0.06 .040∗
middle aged 0.35 ±0.04 .013∗
old 0.40 ±0.09 <.001∗,.008†
Chymotrypsin-like, trypsin-like, and peptidylglutamyl-peptidase activities in the soluble fractions of rat lens homogenate from newborn (7 days, n = 23),
young(2–4months,n = 12),middleaged(10months,n = 4),andold(18–24months,n = 9)rats.Calcium-dependentchymotrypsin-likeactivitywasdeﬁned
as the net diﬀerence between proteolysis of LLVY with and without calcium, respectively. Proteolytic activity is expressed as relative ﬂuorescence units (RFUs)
persecondandgramofprotein.Mean ±SD(standarddeviation)isshown.StatisticalanalysiswasmadeusingANOVAwithBonferroniasposthoc.A P-value
of less than .05 was considered statistically signiﬁcant. N.A. = Not Applicable; in these cases addition of calcium caused an inhibition of the activity, yielding
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(c) Peptidylglutamyl-peptidase activity (LLE)
Figure 1: Michaelis-Menten constants (Km) of the proteasome in rat liver with age: regression plots of Michaelis-Menten constants (Km)o f
the proteasome in rat liver versus age. Km-constants were obtained from Lineweaver-Burk plots generated from proteolytic runs using four
diﬀerent substrate concentrations. For each concentration, triplicate samples were run. (a) Chymotrypsin-like activity: R2 of the regression
line is 0.049, P = .138. (b) Trypsin-like activity: R2 = 0.417, P<. 001. (c) Peptidylglutamyl peptidase activity: R2 = 0.034, P = .219. A
P-value of less than .05 was considered statistically signiﬁcant.
indicating that the changes that occur in proteasome activity
with age are more pronounced during the transition from
sexually immature to mature animal than during senescence.
In accordance with these data, a previous report by Conconi
and Friguet on puriﬁed proteasome from rat liver reported
that Vmax of the chymotrypsin- and the trypsin-like activities
was unaﬀected during aging, whereas the peptidylglutamyl
peptidase activity exhibited an age-related decline [13].
Inthisstudy,thesolublefractionfrombrainhomogenate
of mature and older rat groups (from 2 months to 24
months) exhibited signiﬁcantly lower activity of all three
proteasomal peptidases as compared to the newborn group
(7 days). Again, this may reﬂect changes in proteasomal
function during sexual maturation of the animal, coinciding
with a transition from an immature/newborn stage to a
young adult/fertile stage. The ubiquitin-proteasome system
h a sb e e na s c r i b e dac r u c i a lr o l ei nn e u r o n a lp r o t e i nt u r n o v e r
during development of the nervous system [14]. This decline
in proteasome activities in rat brain is consistent with
previous data from Zeng et al., demonstrating an overall
decreaseinchymotrypsin-andtrypsin-like,aswellasinpep-
tidylglutamyl peptidase activity in middle aged (15 months)
as compared to immature (6 weeks) rats [15]. Interestingly,
they discovered diﬀerences between brain regions and it was
only in substantia nigra that all three peptidase activities
were signiﬁcantly decreased, implying a role in Parkinson’s
disease.
The present data do not demonstrate any change in
proteasomal activity in the aging rat brain after 2 months of
age, consistent with a study from Abd El Mohsen et al., who
did not see any eﬀect by age in rat brain neither in the frontal
cortex, hippocampus, nor in the cerebellum, when compar-
ing rats of 3–5 months and 15-16 months of age [10]. Data
are thus conﬂicting and the discrepancies between studies
may reﬂect diﬀerences in species used or selected age groups.
Itmayalsobeexplainedbydiﬀerentpreparation/puriﬁcation
modes or techniques for proteolytic analysis. Most studies
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(c) Peptidylglutamyl-peptidase activity (LLE)
Figure 2: Michaelis-Menten constants (Km) of the proteasome in rat brain with age. Michaelis-Menten constants of the proteasome in
rat brain plotted against age: Km-values were obtained as described in Figure 1. (a) Chymotrypsin-like activity: R2 = 0.024, P = .291. (b)
Trypsin-like activity: R2 = 0.189, P = .002. (c) Peptidylglutamyl peptidase activity: R2 = 0.060, P = .094. A P-value of less than .05 was
considered statistically signiﬁcant.
enzyme. However, it has been suggested that isolation and
puriﬁcationprocessesleadtoactivationoftheenzyme[16]as
well as to structural changes [17]; so characterization of age-
related changes to the proteasome in this study was carried
outinthesolublefractionofcrudetissuehomogenatesunder
the assumption that it would give a physiologically more
relevantassessmentofproteasomeactivity.Bothendogenous
activatingandinhibiting factorsoftheproteasomehavebeen
isolated [16, 18], indicating the importance of conditions
as close to the native as possible when performing activity
measurements.
Cataract is deﬁned as an opaciﬁcation of the eye lens
leading to impaired vision. Although the exact mechanism
for cataract development has not been elucidated, it is well
known that with aging there is an increasing accumulation
of posttranslationally modiﬁed proteins, which accumulate
to form light-scattering high-molecular weight aggregates
[19, 20]. The aged lens proteins exhibit oxidative changes
and since the proteasome is considered the most important
system in removal of oxidatively damaged proteins [21,
22], this proteolytic machinery has been suggested as an
important mechanism to prevent cataract formation [23].
In the present study, no age-related decline in proteasome
activity could be seen in rat lens homogenate. Instead there
was a slight increase in all three peptidase activities with
aging. It should be remembered, however, that proteolysis
was measured in the soluble fraction of the lenses. Due
to numerous posttranslational changes, there is increased
hydrophobicity of the lens proteins with aging and a gradual
redistribution of proteins from the soluble to the insoluble
fraction. It is possible that there is also a parallel transition
of the proteasome from the soluble to the insoluble proteins,
since the latter should constitute more attractive substrates
for the proteasome, containing a higher proportion of
damaged proteins. This could be one explanation to the
decrease in proteasome activity found in the soluble fraction
of rat lenses in this study. Another possibility is of course an
upregulation of proteasome activity with aging, as a result
of higher demands for proteolytic degradation. Such an
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(c) Peptidylglutamyl-peptidase activity (LLE)
Figure 3: Michaelis-Menten constants (Km) of the proteasome in rat lens with age: Eﬀect of aging on Michaelis-Menten constants of the
proteasome in rat lens. Km-values were calculated as previously described (Materials and Methods, legend Figure 1). (a) Chymotrypsin-like
activity:R2 = 0.008,P = .535.(b)Trypsin-likeactivity:R2 = 0.433,P<. 0001.(c)Peptidylglutamylpeptidaseactivity:R2 = 0.242,P = .0004.
A P-value of less than .05 was considered statistically signiﬁcant.
the lens, that is, the epithelium and the outermost lens ﬁber
layers, since the interior part of the lens lacks cell nuclei as
well as organelles.
The lack of proteolytic decline of the lens proteasome
with aging is in accordance with previous work from
our group, where no correlation of the chymotrypsin-like
proteasomal activity with age could be seen in human lens
epithelium [24] nor was there a decrease in any of the three
proteasomal peptidase activities of human lens nuclei with
aging [25]. However, proteasome activity was signiﬁcantly
lower in lens epithelium or lens nuclei from cataractous
lenses/lens nuclei as compared to clear lenses/lens nuclei, but
whether this is a primary cause or secondary eﬀect is not
clear [24, 25]. A report from Viteri et al. did demonstrate
decreasing proteasome activity in human lenses with aging
[26]. All three peptidase activities declined with aging,
although the peptidylglutamyl peptidase activity was the
most vulnerable, exhibiting a signiﬁcant decrease already for
26–35-year-olds.
Degradation of the substrate LLVY was higher in the
presence of 1mM Ca2+ than without calcium (5mM EDTA).
Addition of the calpain-inhibitor calpastatin did not reduce
calcium-stimulatedactivity,whereaslactacystininhibitedthe
major part of the calcium-dependent LLVY-degradation.
This indicates that calpain activity was not present, or
at least at a very low rate. Instead, calcium-dependent
activity thus measured was mainly due to the chymotrypsin-
like activity of the proteasome. It has been demonstrated
that the proteasome may be regulated by calcium through
binding to a 29kDa activator subunit [27]. This is supported
by ﬁndings from our group indicating that intracellular
proteasome activity in human lens epithelium may be
stimulated by calcium both from external and internal stores
[28].Previousﬁndingsfromourgroupalsodemonstratethat
the chymotrypsin-like activity of the proteasome in intact
mouselenscanbestimulatedbyincreasedintracellularCa2+-
levels [29]. The present study is the ﬁrst to demonstrate
that calcium-stimulated chymotrypsin-like activity of the8 Current Gerontology and Geriatrics Research
proteasome decreases with a transition from sexually imma-
ture (7 days old) to mature/fertile (2–4 months) animal.
This decline was signiﬁcant in the soluble fractions from
rat brain homogenate as well as from lens homogenate.
In rat lens, Ca2+-stimulated chymotrypsin-like activity was
completely abolished in the older age groups and addition of
calcium even had an inhibitory eﬀect on proteasome activity.
Regulation of the proteasome by ﬂuctuations in intracellu-
lar calcium-levels provides an additional mode of regula-
tion than the previously described regulatory mechanisms
through ubiquitination, ATP-levels, GSH/GSSG-ratio, phos-
phorylation, regulatory subunits, and diﬀerent proteasome-
associated proteins [30–34], further emphasizing the impor-
tance for strict regulation of the proteasome system.
Most studies on age-related changes in proteasome activ-
ity have measured speciﬁc activity of puriﬁed proteasome or
tissue homogenates. Few studies have investigated changes
in kinetic properties such as Km with aging. The Michaelis-
Menten constant is deﬁned as the substrate concentration at
1/2 Vmax. Ah i g hKm thus indicates that a higher substrate
concentration is needed to obtain the same rate of enzyme
activity than an enzyme with a lower Km would need.
Correlating the Km-values for a protease with aging hence
gives a view of the age-related change in aﬃnity for a speciﬁc
substrate. In this study, the trypsin-like peptidase activity in
rat liver as well as the trypsin-like and the peptidylglutamyl
peptidase activities in rat lens exhibited signiﬁcant increases
in Km-values with age, indicating declining aﬃnity of the
proteasome for its substrates with maturation and aging.
The trypsin-like activity in rat brain showed an age-
dependent decrease in Michaelis-Menten constant however.
NosigniﬁcantchangeinKm-valuewasseenfortheremaining
peptidase activities in rat liver, brain, and lens. In a previous
study, Conconi et al. found no age-related eﬀect on the
Michaelis-Menten constant for any of the peptidase activities
when comparing puriﬁed proteasome from the liver of 8-
month-old versus 24-month-old rats [13]. Studies on the
aged rat retina [9]a n dr a tl i v e r[ 8] also failed to demonstrate
any signiﬁcant diﬀerences in Km for the chymotrypsin-like,
thetrypsin-like,andthepeptidylglutamylpeptidaseactivities
with age. Data from the present and from previous studies
are thus still inconclusive about age-related changes in the
proteasome’s aﬃnity for its substrates.
The mechanism for the age-related decline in protea-
some activity seen in some previous studies is not fully
elucidated although several possibilities have been discussed
and partially investigated. A few studies have reported
decreased expression of the 20S proteasome with aging
[9, 26], while others have reported reduced contents of
regulatory subunits (PA700 and PA28) and constant or
even increased levels of the immunoproteasome [8]. Post-
translational modiﬁcations of the proteasome with aging
have also been reported [26]a sw e l la sa na g e - r e l a t e d
reduction in ubiquitin conjugation cascade mRNA [35].
In addition, there is a paradoxal relationship between the
proteasome and oxidative stress, which may aﬀect its activity
upon aging. Although the proteasome is known to prefer
mildlyoxidatedproteinstonativeassubstrates[36,37],ithas
alsobeenshownthatproteasomeactivityisinhibitedbylarge
protein aggregates, which are often the result of oxidative
modiﬁcations [38].
The present study, demonstrating increasing Km-values
with maturation and aging in rat liver and rat lens, indicates
that structural changes to the proteasome, leading to lower
aﬃnity for its substrates, may contribute to the age-related
changes in proteasome activity. Our results do not support
a decline in proteasome activity with senescence, however,
but rather emphasize the importance of the ubiquitin-
proteasome system in development and diﬀerentiation early
in life.
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